REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 156 filers reported holding REGENXBIO INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,368,731 | +4.6% | 2,574,042 | +27.0% | 2.02% | +29.6% |
| Q2 2023 | $40,511,254 | +30.6% | 2,026,576 | +23.5% | 1.56% | +15.5% |
| Q1 2023 | $31,026,110 | -28.5% | 1,640,725 | -14.3% | 1.35% | -24.2% |
| Q4 2022 | $43,398,452 | -14.4% | 1,913,512 | -0.2% | 1.78% | -9.7% |
| Q3 2022 | $50,672,000 | +2.3% | 1,917,212 | -4.4% | 1.96% | +3.9% |
| Q2 2022 | $49,515,000 | -24.5% | 2,004,663 | +1.4% | 1.89% | -7.7% |
| Q1 2022 | $65,614,000 | +5.8% | 1,976,923 | +4.2% | 2.05% | +45.2% |
| Q4 2021 | $62,039,000 | -26.3% | 1,897,223 | -5.5% | 1.41% | -4.0% |
| Q3 2021 | $84,175,000 | +1.3% | 2,008,001 | -6.1% | 1.47% | +19.4% |
| Q2 2021 | $83,069,000 | +4.1% | 2,138,201 | -8.6% | 1.23% | +9.3% |
| Q1 2021 | $79,828,000 | -17.1% | 2,340,313 | +10.2% | 1.12% | -3.6% |
| Q4 2020 | $96,322,000 | +57.1% | 2,123,492 | -4.7% | 1.17% | +3.6% |
| Q3 2020 | $61,319,000 | -25.6% | 2,228,166 | -0.4% | 1.13% | -26.0% |
| Q2 2020 | $82,380,000 | +8.8% | 2,236,766 | -4.3% | 1.52% | -28.4% |
| Q1 2020 | $75,720,000 | -26.3% | 2,338,466 | -6.8% | 2.12% | -13.6% |
| Q4 2019 | $102,769,000 | +22.2% | 2,508,386 | +6.2% | 2.46% | -12.7% |
| Q3 2019 | $84,105,000 | +17.7% | 2,362,486 | +69.8% | 2.82% | +39.1% |
| Q2 2019 | $71,475,000 | -12.2% | 1,391,376 | -2.0% | 2.02% | -15.1% |
| Q1 2019 | $81,400,000 | +43.2% | 1,420,342 | +4.8% | 2.38% | +4.2% |
| Q4 2018 | $56,831,000 | -54.5% | 1,354,742 | -18.2% | 2.29% | -40.6% |
| Q3 2018 | $125,033,000 | +11.6% | 1,656,065 | +6.1% | 3.85% | +1.1% |
| Q2 2018 | $112,014,000 | +76.1% | 1,561,175 | -26.7% | 3.80% | +54.9% |
| Q1 2018 | $63,610,000 | +34.2% | 2,130,972 | +49.5% | 2.46% | +19.2% |
| Q4 2017 | $47,390,000 | -13.8% | 1,425,272 | -14.5% | 2.06% | -24.0% |
| Q3 2017 | $54,950,000 | +61.9% | 1,667,672 | -3.0% | 2.71% | +31.2% |
| Q2 2017 | $33,944,000 | +38.6% | 1,718,671 | +35.4% | 2.07% | +29.9% |
| Q1 2017 | $24,494,000 | +301.4% | 1,269,131 | +358.2% | 1.59% | +244.2% |
| Q3 2015 | $6,102,000 | – | 277,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |